Clinical Trials Logo

Bacterial Conjunctivitis clinical trials

View clinical trials related to Bacterial Conjunctivitis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06363292 Recruiting - Clinical trials for Bacterial Conjunctivitis

Study to Evaluate the Safety and Tolerability of PRO-231 Ophthalmic Solution Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects.

Start date: January 30, 2024
Phase: Phase 1
Study type: Interventional

This is a phase I clinical study evaluating the safety and tolerability of PRO-231 ophthalmic solution through the incidence of unexpected adverse events, incidence of conjunctival hyperemia and chemosis, changes in Best Corrected Visual Acuity (BCVA), changes in ocular surface integrity, compared to VIGAMOXI®.

NCT ID: NCT03235141 Recruiting - Clinical trials for Bacterial Conjunctivitis

Local Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers

Start date: July 7, 2017
Phase: Phase 1
Study type: Interventional

To compare the pharmacokinetic behavior of azithromycin eye drops in the tear with the original azithromycin eye drops, and evaluate the release behavior of both in the eye.